BCIQ Profiles

Company Profile Report

Ziopharm slides on news of patient deaths

Ziopharm Oncology Inc. (NASDAQ:ZIOP) lost $0.66 (12%) to $5.01 on Friday after it reported three patient deaths in a Phase I

Read the full 216 word article

How to gain access

Continue reading with a
two-week free trial.